Insiders · Profile

Nash Duane

Executive Chairman at IMMUNIC · Director at Akebia Therapeutics. Filing since 8 Oct 2014. CIK 0001591098

Company
Date
Role
Action
Shares
Amount
Of holding
13 Jun 2025
Executive Chairman
Bought
20,000
$16.69K
125%
12 May 2022
Executive Chairman
Bought
10,000
$50.30K
83.1%
10 Aug 2021
Executive Chairman
Bought
1,000
$9.80K
7.1%
12 May 2021
Executive Chairman
Bought
4,000
$51.00K
39.9%
4 Dec 2019
Director
Sold, plan not stated
4,400
$30.62K
30.5%
15 Feb 2018
Director
Sold, plan not stated
1,000
$14.62K
4.4%
2 Oct 2017
Director
Sold, plan not stated
1,188
$23.33K
5.0%
3 Jul 2017
Director
Sold, plan not stated
990
$14.13K
4.0%
8 Jun 2017
President
Bought
3,900
$12.18K
90.2%
3 Apr 2017
Director
Sold, plan not stated
991
$9.12K
3.9%
3 Jan 2017
Director
Sold, plan not stated
1,980
$20.71K
7.2%
3 Oct 2016
Director
Sold, plan not stated
1,981
$17.75K
6.7%
6 Jul 2016
Director
Sold, plan not stated
1,980
$14.82K
6.3%
2 Oct 2015
Director
Sold, plan not stated
996
$8.62K
3.1%
2 Jul 2015
Director
Sold, plan not stated
996
$9.49K
3.0%
2 Apr 2015
Director
Sold, plan not stated
996
$9.05K
7.7%
2 Jan 2015
Director
Sold, plan not stated
995
$11.40K
7.2%
26 Dec 2014
Director
Sold, plan not stated
5,169
$57.85K
30.4%
24 Dec 2014
Director
Sold, plan not stated
6,764
$76.19K
28.5%
8 Oct 2014
See Remarks
Bought
100
$1.75K
1.1%
20 decisions on file.